Speaker illustration

Associate Professor Krekwit SHINLAPAWITTAYATORN

Chiang Mai University, Chiang Mai (Thailand)

Associate Professor Dr. Krekwit Shinlapawittayatorn received his M.D. from the Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, and Ph.D. in Physiology and Biophysics from Case Western Reserve University (CWRU), USA. He is currently the Head of Cardiac Catheterization Laboratory of the Cardiac Electrophysiology Research and Training (CERT) Center, Faculty of Medicine, Chiang Mai University, and also serves as an Associate Professor in the Department of Physiology, Faculty of Medicine, Chiang Mai University. Currently, he has been studying the cardiac electrophysiological changes during vagus nerve stimulation and during ischemia and reperfusion injury, aging and chemotherapy‐induced cardiotoxicity, using a wide range of study models ranging from cardiac mitochondria, isolated cardiomyocytes, and small as well as large (human-like) animal models to the bedside level for these pathophysiological studies.

Hyperbaric oxygen therapy attenuates D-galactose-induced-age-related cardiac dysfunction through mitigating cardiac mitochondrial dysfunction in pre-diabetic rats

Event: ESC Congress 2020

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

Hyperbaric oxygen therapy attenuates D-galactose-induced-age-related cardiac dysfunction through mitigating cardiac mitochondrial dysfunction in pre-diabetic rats

Event: ESC Asia with APSC & AFC 2020

Topic: Cardiovascular Disease in the Elderly

Session: Abstract Programme

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb